Vaccine Preventable Respiratory Disease in New Zealand

Research Projects Using Growing Up Data

Vaccine Preventable Respiratory Disease in New Zealand

Publication Date:

2017

Lead Organisation:

TBC

Lead Researcher:

Priya Veerasingam

Access Type:

Internal

Primary Classification:

Health and Wellbeing

Secondary Classification:

New Zealand experiences a large disease burden from respiratory tract infections. Hospitalisation at <2 years of age with pneumonia and bronchiolitis leads to persistence of respiratory symptoms 1 year later in at least one-third of children.

Bronchiectasis, which results from recurrent childhood respiratory infections, remains a significant causes of premature death in New Zealand. The potential for this to be prevented by timely immunisation has not been studied. The study will determine the timeliness and completeness of preschool immunisation in NZ, describe recurrent and chronic respiratory disease up to 5 years of age and whether delayed or incomplete immunisations increase the risk of recurrent and chronic respiratory disease.